CPRX
Catalyst Pharmaceuticals, Inc.
$31.47
-0.02 (-0.06%)
At close · Jul 8
Market Cap
$3.85B
Shares
122,380,992
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| David S. Tierney, M.D. | member of the board of directors of the Company and any committee thereof, as applicable | Resigned | 2026-07-08 |
| Tamar Thompson | member of the board of directors of the Company and any committee thereof, as applicable | Resigned | 2026-07-08 |
| Molly Harper | member of the board of directors of the Company and any committee thereof, as applicable | Resigned | 2026-07-08 |
| Donald A. Denkhaus | member of the board of directors of the Company and any committee thereof, as applicable | Resigned | 2026-07-08 |
| Daniel J. Curran, M.D. | member of the board of directors of the Company and any committee thereof, as applicable | Resigned | 2026-07-08 |
| Richard J. Daly | member of the board of directors of the Company and any committee thereof, as applicable | Resigned | 2026-07-08 |
| Patrick J. McEnany | member of the board of directors of the Company and any committee thereof, as applicable | Resigned | 2026-07-08 |